Glucose 6 phosphate dehydrogenase deficiency in Malta : a preliminary study by Cauchi, Maurice N.
30 
GLUCOSE-6-PHOSPHATE DEHYDROGENASE 
DEFICiENCY IN MALTA - A PRELIMINARY STUDY 
MAURICE N. CAUCHI 
M.D. (MALTA), M.sc. (LOND.), PH.D. (LOND.), D.P.H. 
Department of Pathology 
Royal University of Malta 
It has been suggested that glucose-6-
phosphate dehydrogenase deficiency 
(G6PD) affects more than 100 million peo-
ple of all races throughout the world (Car-
son and Frischer, 1966), and that as many 
as 30% of cases of chronic non-spherocytic 
haemolytic anaemia are associated with a 
form of G6PD deficiency (Wintrobe, 1967). 
The special relevance of this problem to 
Malta can readily be appreciated when it 
is remembered that G6PD deficiency is 
particularly common in countries border-
ing the Mediterranean. In some surveys 
up to 32% of Greeks and 35% of Italians 
tested were G.6PD deficient (WHO, 1967). 
G6PD is an enzyme present in red 
cells and catalyzes the reaction: 
G6PD - i 6PG (fig. 1). During this pro-
cess NADP (nicotinamide adenine dinu-
cleotide phosphate) is reduced to NADPH 
which is essential for keeping glutathione 
(GSSG) in the reduced state (GSH). This 
is called t.he Pentose Phosphate pathway, 
and although only about 20% of glu-
cose-6-phosphate is metabolised via this 
mechanism, all NADPH required by the 
cell is produced in this way. 
etc. The introduction of 8-aminoquinoline 
in 1926 as an antimalaria drug has been 
associated with severe and even fatal 
haemolysis. The list of drugs known to 
affect deficient individuals has grown con-
siderably in recent years, and includes 
sulphapyridine, sulphadiazine, primaquine, 
trinitrotoluene, quindine, naphthalin2, 
nitrite, and chloramphenicol (WHO, 1967). 
The inheritance of G6PD deficiency 
follows a well described pattern. The locus 
responsible for this enzyme is situated on 
the X-chromosome, so that this condition 
is transmitted as a sex-linked character 
affecting males (hemizygotes) - female 
carrying one affected chromosome (hetero-
zygotes) show varying degrees of enzyme 
deficiency. 
Methods of Study 
Various screening procedures have 
been described to detect G6PD deficiency, 
including the Methaemoglobin reduction 
test (Breuer et al., 1962), the M.T.T. linked 
spot test (Fairbanks and Beutler, 1962), 
the Methylene Blue absorption test (Oski 
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Fig. 1. Role of G6PD in the production of NADPH 
The consequences of G6PD deficiency 
have been known for a long time. Haemoly-
sis following ingestion of certain beans has 
been called favism, Baghdad Spring Fever, 
and Growney, 1965, Sass et al., 1966), the 
fluorescent test (Beutler, 1966), and the 
ascorbic acid cyanide test (Rakitzis, 1964, 
Jacob and Jandl, 1966). The screening me-
thod used here is that described by MotuJ-
sky and Campbell-Kraus, 1961). This test 
is based on the principle that the dye Bril-
liant Cresyl Blue (BCB) is reduced to a 
colourless state by the action of NADPH 
produced through the action of G6PD. 
For this test 0.02 ml of blood is added 
to 1 ml distilled water. To this are added 
0.01 ml Sodium G6P (825 mg/lOOml), 
0.1 ml NADP (50 mg/lO ml), 0.25 ml BCB 
(32 mg/100 ml) and 0.2 ml TRIS buffer 
(pH 8.5): 8.96 gm/97 ml + 3 ml HCI. The 
mixture is covered by paraffin oil, and 
incubated at 37°C. The time taken for 
decolourisation to take place is an index 
of G6PD activity in the red cells. Normally 
specimens decolorise by 65 mins. 
These screening procedures have the 
great advantage of being quick, and simple 
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to perform, so that large numbers of tests 
can be done at the same time. For more 
detailed investigation of those cases that 
show enzyme deficiency by the screening 
test, a more accurate but more laborious 
quantitative test is done. Basically the 
test depends on the increase in absorb-
ance at 340 mu following the production 
of NADPH. 
The relationship between the BCB 
tests (in minutes) and the quantitative 
tests (in units/lOO ml packed cells) is not 
a linear one as seen in the following expe-
riment: 
For the BCB (qualitative) test, sam-
ples of blood were taken and diluted so 
as to contain 20, 15, 10, 5 and 0 u litres/ 
ml of distilled water. The time taken for 
decolourisation of the BCB after incuba-
Fig. 2: The effect of dilution 
on decolourisation time in the 
BCB test. 
Fig. 3: The effect of dilution 
on the activity of samples as 
measured by the quantitative 
test (units/IOOml packed cells). 
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tion is shown in fig. 2. It is seen that the 
rate of decolourisation is a function of the 
volume of blood examined: when 20 ul of 
blood were used decolourisation occurred 
in 40 minutes, whereas when only 5 ul 
were used, decolourisation occurred in 110 
minutes; i.e. a low activity of G6PD is 
associated with long decolourisation times. 
For the quantitative test, samples 
(from the same blood as used above) con-
taining 0.2, 0.1, 0.05, 0.02, and 0.01 ml 
were tested and the quantity of G6PD was 
estimated quantitatively (units/lOO ml 
packed cells). It is seen (fig. 3) that 0.2 ml 
blood - the quantity normally taken for 
the test - contained an activity equivalent 
to 0.54 units, whereas no activity was 
measurable in 0.02 ml blood. 
If one plots the results obtained by 
the BeB test against those obtained by the 
quantitative method (fig. 4), it is seen that 
100% activity is equivalent to a decolouri-
sation time of 40 min (BeB test) and 0.54 
units (quantitative test); 50% activity is 
equivalent to a decolourisation time of 60 
Fig. 4: Correlation between 
the result of the BeR test 
(minutes) and the quantitative 
test (units/lOO ml. packed cells). 
minutes and 0.183 units respectively; 
while 5% activity is equivalent to llO min. 
decolourisation time, and 0 units/lOO ml 
respectively (Table 1). In other words, the 
relationship between the results from the 
BeB test and the quantitative test is not 
linear. 
G6PD Survey 
For the purpose of the survey samples 
of blood were obtained from the follow-
ing: i) normal people - blood donors, stu-
dents at various colleges, and staff; ii) pa-
tients from the wards at St. Luke's Hos-
pital suffering from a variety of surgical 
or medical disorders; and iii) diabetic pa-
tients under treatment. The results are 
tabulated in table 2. 
800 samples were examined: 555 
males and 245 females. Ten males and 2 
females were found to be enzyme deficient 
- an incidence of 1.8% and 0.8% respec-
tively. There was no significant difference 
between the diabetic and either the nor-
Table 1. Relation between BCB tests 
and the Quantitative Estimation of G6PD 
Sample 
1 
2 
3 
4 
5 
6 
Activity as % of BBC Test 
original dilution 
100% 
75% 
50% 
25% 
10% 
5% 
minutes 
40 
50 
60 
llO 
Quantitative Test 
units / lOO 1111 packed cells 
.54 
.183 
.131 
o 
o 
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Table 2. Incidence of G6PD Deficiency 
MALES 
No. Examined Affected % 
Normal 269 5 1.86 
Patients 187 3 1.61 
Diabetics 99 9 2.2 
Total 555 10 1.8 
mal or the ordinary patients groups. 
The lower incidence of G6PD defi-
ciency in females can be explained by the 
relative lack of sensitivity of the BeB test 
in heterozygotes. 
Work is going on at the moment in 
order to establish whether the incidence 
of G6PD deficiency varies from one part 
of the Island to the other. 
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FEMALES 
No. Examined Affected % 
27 
46 
172 2 1.17 
245 2 0.81 
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